Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables.

Background and Aims: A recent study found that homeless individuals with opioid use disorder (OUD) had a lower risk of relapse on extended‐release naltrexone (XR‐NTX) versus buprenorphine–naloxone (BUP‐NX), whereas non‐homeless individuals had a lower risk of relapse on BUP‐NX. This secondary study...

Descripción completa

Detalles Bibliográficos
Publicado en:Addiction Vol. 116; no. 8; pp. 2094 - 2104
Autores principales: Rudolph, Kara E., Díaz, Iván, Hejazi, Nima S., Laan, Mark J., Luo, Sean X., Shulman, Matisyahu, Campbell, Aimee, Rotrosen, John, Nunes, Edward V.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Aug2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151210158&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 151210158
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: Aug2021
      vid: 116
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        151210158
        148223815
        151210158
        151210158
        10.1111/add.15377
        151210158
      ppf: 2094
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables.
      aug:
        au:
          Rudolph, Kara E.
          Díaz, Iván
          Hejazi, Nima S.
          Laan, Mark J.
          Luo, Sean X.
          Shulman, Matisyahu
          Campbell, Aimee
          Rotrosen, John
          Nunes, Edward V.
        affil: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York NY,, USA
      sug:
        subj:
          Substance Use Disorders Drug Therapy
          Homelessness Psychosocial Factors
          Naltrexone Administration and Dosage
          Buprenorphine Administration and Dosage
          Naloxone Administration and Dosage
          Drug Therapy, Combination
          Recurrence Risk Factors
          Risk Assessment
          Human
          Secondary Analysis
          Communities
          United States
          Adult
          DSM
          Inpatients
          Patient Admission
          Descriptive Statistics
          Mediation Analysis
          Patient Compliance
          Depression
          Pain
          Confidence Intervals
          Treatment Outcomes
          Adult: 19-44 years
      ab: Background and Aims: A recent study found that homeless individuals with opioid use disorder (OUD) had a lower risk of relapse on extended‐release naltrexone (XR‐NTX) versus buprenorphine–naloxone (BUP‐NX), whereas non‐homeless individuals had a lower risk of relapse on BUP‐NX. This secondary study examined differences in mediation pathways to medication effect between homeless and non‐homeless participants. Design Secondary analysis of an open‐label randomized controlled, 24‐week comparative effectiveness trial, 2014–17. Setting: Eight community addiction treatment programs in the United States. Participants: English‐speaking adults with DSM‐5 OUD, recruited during inpatient admission (n = 570). Intervention(s): Randomization to monthly injection of XR‐NTX or daily sublingual BUP‐NX. Measurements(s): Mediation analysis estimated the direct effect of XR‐NTX versus BUP‐NX on relapse and indirect effect through mediators of medication adherence, use of illicit opioids, depressive symptoms and pain, separately by homeless status. Findings For the homeless subgroup, the protective indirect path contributed a 3.4 percentage point reduced risk of relapse [95% confidence interval (CI) = −12.0, 5.3] comparing XR‐NTX to BUP‐NX (explaining 21% of the total effect). For the non‐homeless subgroup, the indirect path contributed a 9.4 percentage point increased risk of relapse (95% CI = 3.1, 15.7) comparing XR‐NTX to BUP‐NX (explaining 57% of the total effect). Conclusions: A novel approach to mediation analysis shows that much of the difference in medication effectiveness (extended‐release naltrexone versus buprenorphine–naloxone) on opioid relapse among non‐homeless adults with opioid use disorder appears to be explained by mediators of adherence, illicit opioid use, depressive symptoms and pain.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N